Delivery Order SPE2DB25D3306-SPE2DB25FUCZK
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $1,333.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Femring 0.05 mg/day vaginal rings. This non-competitive delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,161.77 to supply Femring 0.05 mg/day vaginal rings, with an ultimate completion date of September 22, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement supporting federal medical supply needs. The order will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Femring 0.05 mg/day vaginal rings with a ceiling value of $1,159.81 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,651.13 for the supply of FEMRING 0.05 mg/day vaginal rings under a contract funded by the Defense Logistics Agency's Medical Supply Chain. The award, made on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed price delivery order with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $855.68 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 4562002078 FEMRING 0.10 MG/DAY VAGINAL RINGS. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 30, 2023 through August 31, 2023. No set aside designation or subcontracting details were provided. The...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of FEMRING 0.05 MG/DAY vaginal rings, with a potential value of $2,884.82 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- This is a $1,193.47 fixed-price delivery order awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings to the U.S. government. The award was made by the Medical Supply Chain, a defense agency under the Defense Logistics Agency (DLA) Troop Support. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,069.10, is a delivery order for the supply of FEMRING 0.10 MG/DAY VAG RINGS, a pharmaceutical product. The contract has a period of performance through October 16, 2024 and utilizes a firm fixed-price pricing structure. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,558.51, is a delivery order for the supply of FEMRING 0.05 MG/DAY vaginal rings. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,288.87, is a delivery order for the supply of FEMRING 0.10 MG/DAY VAG RINGS, a vaginal ring medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 1, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC)...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCZKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,635.97 to AmerisourceBergen Drug Corp for the supply of Femring 0.05 mg/day vaginal rings. This is a firm fixed-price, non-set-aside contract awarded on September 18, 2025, with a completion date of September 19, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company has demonstrated capability to fulfill diverse federal medical supply requirements through competitive procurement, with its contract portfolio encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, with AmerisourceBergen positioned as a potential provider to support customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/18/25 |